| Product ID |
Product Name |
CAS# |
Purity |
| Y3267885 |
(4-Chloro-2,6-dimethyl-phenyl)methanol |
332179-32-5 |
95% |
| Y3267197 |
(2-Chloro-5-fluoro-3-methyl-phenyl)methanol |
1807237-14-4 |
95% |
| Y3254103 |
1-Bromo-4,5-difluoro-2-isopropoxy-benzene |
1266253-67-1 |
95% |
| Y3255879 |
3-Chloro-6-fluoro-2-methoxy-benzaldehyde |
1646821-91-1 |
95% |
| Y3238438 |
6-Bromo-1,1,1,2,2-pentafluoro-hexane |
1379347-61-1 |
95% |
| Y3254143 |
[2-Bromo-4-(trifluoromethoxy)phenyl]methanol |
1316273-53-6 |
95% |
| Y3293760 |
N-(4-{2-methyl-4-oxo-3H,4H-pyrido[2,3-d]pyrimidin-3-yl}phenyl)-[1,1'-biphenyl]-4-carboxamide |
1005304-44-8 |
99% |
| Y3227034 |
4-(Difluoromethyl)-3-fluoroanilinehydrochloride |
2648962-08-5 |
95% |
| Y3231943 |
N-(cyanomethyl)-N-methylcarbamoylchloride |
5524-30-1 |
95% |
| Y3259097 |
1-Bromo-3-(difluoromethoxy)-5-(trifluoromethyl)benzene |
1417567-27-1 |
95% |
| Y3308614 |
N-[4-(1H-1,3-benzodiazol-2-yl)phenyl]-2,4-dimethoxybenzamide |
476633-98-4 |
95% |
| Y3249025 |
3-(3-Bromo-4-methylphenyl)-1,2,4-oxadiazole |
1262412-82-7 |
95% |
| Y3244181 |
(3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diaminedihydrochloride |
92418-36-5 |
95% |
| Y3268864 |
1-Methyl-4-(p-tolylmethyl)pyrazole |
2484889-30-5 |
95% |
| Y3310879 |
Ethyl4-methoxy-2-(trifluoromethoxy)benzoate |
1186195-26-5 |
95% |
| Y1262406 |
AES-135 |
2361659-61-0 |
98% |
| Y3234460 |
Plecanatide acetate |
1075732-84-1 |
99% |
| Y1253743 |
Sirt2-IN-1 |
1862238-00-3 |
98% |
| Y1262407 |
MC180295 |
2237942-08-2 |
98% |
| Y1253730 |
SCD1 inhibitor-1 |
1069094-65-0 |
99% |
| Y1262408 |
CDK9-IN-7 |
2369981-71-3 |
99% |
| Y1257975 |
dBET57 |
1883863-52-2 |
97% |
| Y3295675 |
PROTAC RAR Degrader-1 |
1351169-27-1 |
97% |
| Y3249980 |
Mal-PEG2-VCP-Eribulin |
2130869-18-8 |
99% |
| Y1262476 |
Succinyl phosphonate trisodium salt |
864167-45-3 |
98% |
| Y1340261 |
Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH |
2351103-63-2 |
98% |
| Y3297214 |
GNA002 |
1385035-79-9 |
98% |
| Y3225926 |
SC-VC-PAB-MMAE |
2259318-46-0 |
98% |
| Y3295984 |
TD-0212 TFA |
1073549-11-7 |
98% |
| Y1266689 |
AR453588 |
1065609-00-8 |
99% |
| Y1253732 |
SARS-CoV-IN-3 |
888958-27-8 |
99% |
| Y3268410 |
CH6953755 |
2055918-71-1 |
98% |
| Y1258056 |
CBS1117 |
959245-08-0 |
99% |
| Y3310558 |
NSC745885 |
4219-52-7 |
98.0% |
| Y3289508 |
XZ739 |
2365172-19-4 |
98% |
| Y1340150 |
Thalidomide-NH-C6-NH-Boc |
2093536-13-9 |
98% |
| Y3233442 |
THZ-P1-2 |
2058075-45-7 |
99% |
| Y1253734 |
MRK-740 |
2387510-80-5 |
99% |
| Y3317314 |
Cholecystokinin Octapeptide, desulfated TFA |
171486-94-5 |
98% |
| Y3233651 |
MKK7-COV-9 |
2283355-59-7 |
97% |
| Y1258101 |
PROTAC RIPK degrader-6 |
2089205-64-9 |
99% |
| Y3308051 |
Hydroxy--sanshool |
78886-66-5 |
95% |
| Y3262878 |
6-Methoxytricin |
76015-42-4 |
98% |
| Y1258058 |
Proanthocyanidin A4 |
111466-29-6 |
99% |
| Y3311461 |
Bacopaside V |
620592-16-7 |
95% |
| Y3311657 |
Leptomerine |
22048-97-1 |
98% |
| Y3234195 |
Salvianolic acid E |
142998-46-7 |
97% |
| Y3308637 |
1-(2-bromoethyl)-2-(bromomethyl)benzene |
38256-56-3 |
95% |
| Y1262478 |
N-(2,6-dibromopyridin-3-yl)-N-methylamine |
84539-50-4 |
97% |
| Y3245704 |
1-benzoyl-4-nitrosopiperazine |
73742-55-9 |
95% |
| Y3312975 |
2-(benzyloxy)-3,4-dimethoxybenzaldehyde |
6527-13-5 |
95% |
| Y3251075 |
(2-iodo-5-methoxyphenyl)acetic acid |
73029-52-4 |
95% |
| Y3249802 |
2,2,2-trichloro-1-(5-methyl-1H-pyrrol-2-yl)ethanone |
183268-72-6 |
95% |
| Y3291863 |
Petesicatib |
1252637-35-6 |
99% |
| Y3287441 |
PROTAC Sirt2 Degrader-1 |
2098487-75-1 |
98% |
| Y1343754 |
STL127705 |
1326852-06-5 |
98% |
| Y3291285 |
FLT3-IN-3 |
2229050-90-0 |
99% |
| Y1253746 |
TAM-IN-2 |
2135642-56-5 |
99% |
| Y3305055 |
M-89 |
2363165-42-6 |
99% |
| Y3287676 |
Complement C5-IN-1 |
2365402-67-9 |
99% |
| Y3308369 |
Adrenocorticotropic Hormone (ACTH) (18-39), human TFA |
73724-75-1 |
100% |
| Y3244335 |
Liarozole dihydrochloride |
1883548-96-6 |
99% |
| Y3245225 |
Licoflavone A |
61153-77-3 |
99% |
| Y3318813 |
PEG4-aminooxy-MMAF |
1415246-35-3 |
99.83% |
| Y3294984 |
Mogroside II-A |
1613527-65-3 |
99% |
| Y3244369 |
MC-GGFG-DX8951 |
1600418-29-8 |
99% |
| Y3297323 |
EN40 |
2094547-67-6 |
99% |
| Y1258120 |
S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate |
2127875-65-2 |
97% |
| Y3310734 |
CB1151 |
182369-28-4 |
95.0% |
| Y3245420 |
Ibrutinib-MPEA |
1710768-30-1 |
99% |
| Y1253671 |
Boc-C1-PEG3-C4-OBn |
2381196-81-0 |
95% |
| Y3286449 |
Quercetin 3-O-(6''-galloyl)-ß-D-galactopyranoside |
53171-28-1 |
powder |
| Y3251076 |
AZD2423 |
1229603-37-5 |
99% |
| Y3250506 |
Stafia-1-dipivaloyloxymethyl ester |
2582755-72-2 |
98% |
| Y3286421 |
X77 |
2455518-33-7 |
99% |
| Y3235104 |
IPN60090 dihydrochloride |
2102101-72-2 |
99% |
| Y3311633 |
Cardiotoxin Analog (CTX) IV (6-12) |
115722-23-1 |
99.75% |
| Y1262402 |
PF-4191834 |
1029317-21-2 |
99% |
| Y3297415 |
Isoagarotetrol |
104060-61-9 |
98% |
| Y3310780 |
11-Deoxymogroside IIIE |
1793003-47-0 |
98% |
| Y3237252 |
XMU-MP-3 |
2031152-08-4 |
98% |
| Y3244830 |
Lusianthridin |
87530-30-1 |
98.0% |
| Y3236904 |
2-Methoxy-4-(methylthio)pyridine-5-boronic acid |
1451392-18-9 |
95% |
| Y3250545 |
3-Bromo-5-methyl-2-(methylthio)pyridine |
1289049-50-8 |
95% |
| Y1253672 |
OSMI-4 |
2260791-14-6 |
99% |
| Y1258006 |
GNE-207 |
2158266-58-9 |
98% |
| Y3285972 |
STAT3-IN-3 |
2361304-26-7 |
98% |
| Y3290957 |
PROTAC ERa Degrader-2 |
1351169-29-3 |
98% |
| Y3249417 |
Sulfo-ara-F-NMN |
1374663-29-2 |
98% |
| Y3289131 |
SIAIS178 |
2376047-73-1 |
99% |
| Y3296552 |
CP5V |
2509359-75-3 |
98% |
| Y3243126 |
FK706 |
144055-55-0 |
99% |
| Y1258121 |
Desethyl chloroquine diphosphate |
247912-76-1 |
99% |
| Y3270546 |
K-Ras ligand-Linker Conjugate 6 |
2378261-89-1 |
98% |
| Y3268678 |
5-Chloro-2-(methylthio)benzaldehyde |
91827-45-1 |
95% |
| Y1262403 |
SARS-CoV-IN-2 |
888958-26-7 |
98% |
| Y3247591 |
Mc-VC-PAB-SN38 |
1801838-28-7 |
98% |
| Y1262404 |
RO2959 monohydrochloride |
2309172-44-7 |
99% |
| Y1253725 |
1-(5-chloro-2-fluorobenzoyl)piperidin-4-amine HCl |
1583080-82-3 |
95%+ |
| Y1253673 |
Licoflavone B |
91433-17-9 |
99% |